GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Yidu Tech Inc (HKSE:02158) » Definitions » Short Percentage of Float

Yidu Tech (HKSE:02158) Short Percentage of Float


View and export this data going back to 2021. Start your Free Trial

What is Yidu Tech Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of Yidu Tech's Short Percentage of Float

For the Health Information Services subindustry, Yidu Tech's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yidu Tech's Short Percentage of Float Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yidu Tech's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Yidu Tech's Short Percentage of Float falls into.



Yidu Tech (HKSE:02158) Business Description

Traded in Other Exchanges
Address
No.9 Building of Huayuan North Road, 8th Floor Health Work, Haidian District, Beijing, CHN
Yidu Tech offers healthcare Big Data. It is an AI cloud-based firm providing solutions and tools to aid in more informed decisions to drive better efficiency in clients' strategies. Its clients are hospitals, pharmaceutical, biotech and medical device firms, research institutions, insurance companies, patients, and regulators. It three business segments are: Big Data platform and solutions, which partners with hospitals and policymakers to drive better efficiency; life sciences solutions, which enables better probability of clinical trial success with less drug development time and cost; and health management solutions, which helps with patient management. The Big Data platform accounted for 33% of revenue, life science solutions 30%, and health management solutions 27%, in fiscal 2022.
Executives
Gong Yingying 2202 Interest of your spouse
Xu Jiming 2101 Beneficial owner
Brunei Investment Agency 2101 Beneficial owner
Gic Private Limited 2102 Investment manager
Sweet Panda Limited 2101 Beneficial owner

Yidu Tech (HKSE:02158) Headlines

No Headlines